1. U.F. Guideline, Elemental impurities in drug products guidance for industry, pharmaceutical quality/CMC, (2018).
2. U. Chapter, <233> Elemental impurities limits, United state Pharmacopeia, the national formulary, USP-38-NF33, US Pharmacopeial Forum, (2015).
3. U. Chapter, <232> Elemental impurities limits, United state Pharmacopeia, the national formulary, USP-40-NF35, US Pharmacopeial Forum, (2017).
4. Q.D.R. ICH Guideline for elemental impurities, International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use, (2019).
5. K. Janchevska, T. Stafilov, S. Memed-Sejfulah, M. Bogdanoska, S. Ugarkovic and G. Petrushevski, ICH Q3D based elemental impurities study in liquid pharmaceutical dosage form with high daily intake–comparative analysis by ICP-OES and ICP-MS. Drug Dev Ind Pharm., 46 (2020) 456–461.